Hep B vaccine protects for at least 15 years

Key points
- After receiving three doses of hepatitis B vaccine, people are protected against infection for at least 15 years, a new study shows.
- Hepatitis B virus can be transmitted through unprotected sex, injection drug use and being exposed to infected blood.
- Previous reports have shown that hepatitis B vaccination provides protection for 10 years.
- McMahon, from the Centers for Disease Control and Prevention in Atlanta, and colleagues reviewed data on 1578 Alaska Natives who were vaccinated at 6 months of age and older.
After receiving three doses of hepatitis B vaccine, people are protected against infection for at least 15 years, a new study shows. This finding argues against the need for booster doses of the vaccine.
Hepatitis B virus can be transmitted through unprotected sex, injection drug use and being exposed to infected blood. The infection can be chronic and lead to liver damage and cancer.
Previous reports have shown that hepatitis B vaccination provides protection for 10 years. However, the duration of protection beyond this period was unclear.
To investigate, Dr. Brian J. McMahon, from the Centers for Disease Control and Prevention in Atlanta, and colleagues reviewed data on 1578 Alaska Natives who were vaccinated at 6 months of age and older. Between 1981 and 1982, they received three doses of hepatitis B vaccine.
In all age groups, hepatitis B vaccination "strongly protected against infection for at least 15 years," the authors report in the March 1st issue of the Annals of Internal Medicine
These findings argue against a need for booster doses of hepatitis B vaccine, Dr. Ding-Shinn Chen, from the National Taiwan University College of Medicine in Taipei, contends. "Unless continued follow-up and surveillance show clinically significant rates of infection in adolescents or adults who were vaccinated as children, booster vaccinations will be wasteful," Chen writes in a perspective piece in the journal.
SOURCE: Annals of Internal Medicine, March 1, 2005.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsHIV Vaccine Development May Be Guided By Antibody Evolution
Observing the evolution of a particular type of antibody in an infected HIV-1 patient, a study spearheaded by Duke University, including analysis from Los Alamos National Laboratory, has provided insights that will…
11 April 2013
NewsCurrent HPV vaccine may not help some women with immune problems
Women with HIV acquire cancer-causing forms of the human papillomavirus (HPV) that are not included in the current HPV vaccines Gardasil and Cervarix, according to new research from Fox Chase Cancer Center being…
8 April 2013
NewsResearchers find potential map to more effective HIV vaccine
By tracking the very earliest days of one person's robust immune response to HIV, researchers have charted a new route for developing a long-sought vaccine that could boost the body's ability to neutralize the virus.…
4 April 2013



